You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

early multiple myeloma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in Cleveland (Multiple

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • Multiple Myeloma M-Protein Analysis
  • Multiple Myeloma Knowledge Questionnaires
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Apr 26, 2023

Prognosis Based on cfDNA Methylation in Multiple Myeloma

Recruiting
  • Multiple Myeloma
  • cfDNA methylation assessment
  • Tianjin, Tianjin, China
    National Clinical Research Center for Blood Diseases, Blood Dise
Jan 11, 2023

Multiple Myeloma Trial in Miami (Teclistamab, Talquetamab, Daratumumab SC)

Not yet recruiting
  • Multiple Myeloma
  • Miami, Florida
    University of Miami
Oct 20, 2023

Multiple Myeloma Trial in Cleveland (Palliative Care, FACT-MM questionnaire, HADS questionnaire)

Recruiting
  • Multiple Myeloma
  • Palliative Care
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Jan 17, 2023

Multiple Myeloma Trial in Birmingham (ARM A EARLY INTERVENTION GROUP, ARM B DELAYED INTERVENTION GROUP)

Active, not recruiting
  • Multiple Myeloma
  • ARM A EARLY INTERVENTION GROUP
  • ARM B DELAYED INTERVENTION GROUP
  • Birmingham, Alabama
    University of Alabama at Birmingham
Nov 29, 2022

Multiple Myeloma Trial in Rouen (Early oncological supportive care, Delayed oncological supportive care)

Recruiting
  • Multiple Myeloma
  • Early oncological supportive care
  • Delayed oncological supportive care
  • Rouen, France
    Centre Henri Becquerel
Dec 22, 2022

Multiple Myeloma, Plasma Cell Leukemia Trial in Shanghai (Human BCMA targeted CAR-NK cells injection)

Recruiting
  • Multiple Myeloma
  • Plasma Cell Leukemia
  • Human BCMA targeted CAR-NK cells injection
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Sep 13, 2023

Multiple Myeloma Trial in Little Rock (Carfilzomib, Thalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Sep 1, 2022

Multiple Myeloma Trial in Saint Louis (drug, device, procedure)

Recruiting
  • Multiple Myeloma
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 27, 2022

Multiple Myeloma, Complication Trial in Lyon (Interpretation of the results from the detection visit, Explaining detection

Not yet recruiting
  • Multiple Myeloma
  • Complication
  • Interpretation of the results from the detection visit
  • +3 more
  • Lyon, France
    Centre Léon Bérard
Jul 7, 2023

Prostate Cancer, Multiple Myeloma, Smoldering Multiple Myeloma (SMM) Trial in Rochester (Curcumin plus Piperine)

Recruiting
  • Prostate Cancer
  • +3 more
  • Curcumin plus Piperine
  • Rochester, New York
    University of Rochester
Jun 17, 2022

High-Risk de Novo Multiple Myeloma Trial in Spain (Daratumumab, Bortezomib, Lenalidomide)

Not yet recruiting
  • High-Risk de Novo Multiple Myeloma
  • Badalona, Spain
  • +9 more
Apr 27, 2023

Multiple Myeloma Trial in Austria, Germany, Israel (Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA], Placebo 1.7 ml

Active, not recruiting
  • Multiple Myeloma
  • Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA]
  • Placebo 1.7 ml Subcutaneous Solution
  • Graz, Austria
  • +9 more
Aug 24, 2022

Breast, Prostate, Colorectal, Liver, or Kidney Cancer or

Recruiting
  • Breast Carcinoma
  • +7 more
  • Biospecimen Collection
  • Laboratory Biomarker Analysis
  • Rockville, Maryland
    National Cancer Institute Division of Cancer Prevention
Jun 29, 2022

Multiple Myeloma Trial in Milan (Temferon)

Terminated
Has Results
  • Multiple Myeloma
  • Milan, Italy
    Ospedale San Raffaele
Jan 27, 2022

Validation for Early Cancer Detection and Minimal Residual

Recruiting
  • Brain Cancer
  • +19 more
    • Duarte, California
    • +6 more
    Nov 10, 2022

    Multiple Myeloma Trial in Shanghai (Human Derived anti-BCMA CAR-T Injection)

    Recruiting
    • Multiple Myeloma
    • Human Derived anti-BCMA CAR-T Injection
    • Shanghai, Shanghai, China
      Shanghai Changzheng Hospital
    Mar 27, 2022

    Multiple Myeloma Trial in Nagoya-shi, Shibukawa-shi, Osaka-shi (Elotuzumab, Lenalidomide, Dexamethasone)

    No longer available
    • Multiple Myeloma
    • Nagoya-shi, Aichi, Japan
    • +3 more
    Nov 17, 2021

    Multiple Myeloma Trial in Boston (CIML NK Cells plus KP1237 and low dose IL-2)

    Recruiting
    • Multiple Myeloma
    • CIML NK Cells plus KP1237 and low dose IL-2
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 18, 2022

    Biology and Genetics of Smouldering Myeloma

    Recruiting
    • Smouldering Myeloma
    • +2 more
    • No intervention
    • London, United Kingdom
      University College London Hospitals
    Sep 15, 2021

    Leukemia, Lymphoma, Multiple Myeloma Trial in Calgary (Early palliative and supportive care)

    Not yet recruiting
    • Leukemia
    • +4 more
    • Early palliative and supportive care
    • Calgary, Alberta, Canada
      Tom Baker Cancer Centre
    Dec 29, 2021

    Relapsed/Refractory Diffuse Large B-cell Lymphoma and Multiples Myeloma Trial in Dresden (MDC-CAR-BCMA001 (BCMA directed CAR

    Not yet recruiting
    • Relapsed/Refractory Diffuse Large B-cell Lymphoma and Multiples Myeloma
    • MDC-CAR-BCMA001 (BCMA directed CAR T-cells)
    • Dresden, Germany
      Technische Universität Dresden, NCT/UCC, Early Clinical Trial Un
    Apr 19, 2023

    Multiple Myeloma Trial in Würzburg, Pamplona (SLAMF7 CAR-T)

    Recruiting
    • Multiple Myeloma
    • SLAMF7 CAR-T
    • Würzburg, Germany
    • +1 more
    Oct 5, 2021

    MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular

    Recruiting
    • Monoclonal Gammopathy of Undetermined Significance (MGUS)
    • +8 more
      • Boston, Massachusetts
      • +6 more
      Apr 14, 2022

      Project in First-degree Relatives of Myeloma Patient - The

      Recruiting
      • Multiple Myeloma
      • Monoclonal Gammopathy of Undetermined Significance
      • Sample of Blood
      • Shanghai, Shanghai, China
        Zhongshan Hospital，Fudan University
      Jul 31, 2023